{ "run": { "id": "cmnqz7ngt00wjp658xw8lvf2w", "region": "BR", "assetId": "cmnqz7nfd00w3p658zhqrby66", "ticker": "NATU3", "snapshotId": "cmnqz7ngd00wdp658itsamxd9", "promptTemplateId": "cmnqt07si0005lm3jzpxuu1ux", "createdAt": "2026-04-09T04:27:47.979Z", "promptTemplate": { "id": "cmnqt07si0005lm3jzpxuu1ux", "name": "Oficial 08.apr.2026", "version": 1 }, "snapshot": { "id": "cmnqz7ngd00wdp658itsamxd9", "assetId": "cmnqz7nfd00w3p658zhqrby66", "asOf": "2026-04-08T21:30:33.000Z", "snapshot": { "asOf": "2026-04-08T21:30:33.000Z", "quote": { "asOf": "2026-04-08T21:30:33.000Z", "open": 10.72, "price": 10.35, "dayLow": 10.33, "volume": 8621900, "dayHigh": 10.72, "currency": "BRL", "prevClose": 10.41, "week52Low": 7.13, "week52High": 11.3 }, "fundamentals": { "pe": 0, "beta": 0, "epsTTM": -1.3475965, "fcfTTM": -2094724000, "growth": { "epsYoy": -7.25534, "revenueYoy": 1.9189798 }, "sector": "Consumo Não Cíclico", "margins": { "net": -0.3304454, "gross": 0.6636247, "operating": 0.063702464 }, "website": "https://www.natura.com.br", "industry": "Produtos de Uso Pessoal", "pegRatio": 0, "ebitdaTTM": 2196115000, "forwardPe": 0, "marketCap": 14059746977, "totalCash": 2342460000, "totalDebt": 8689461000, "debtEquity": 0.5776431, "quickRatio": 1.4126438, "revenueTTM": 21462184000, "companyName": "Natura Cosmeticos SA", "priceToBook": 0.9456912, "currentRatio": 1.6819276, "dividendYield": null, "returnOnAssets": -0.20341794, "returnOnEquity": -0.47145516, "analystOpinions": 0, "businessSummary": "Natura &Co Holding S.A. é uma multinacional brasileira de cosméticos e produtos de higiene pessoal, sendo uma das maiores empresas de beleza do mundo. Fundada em 1969 por Luiz Seabra, a Natura começou como uma pequena loja de cosméticos naturais em São Paulo e evoluiu para se tornar um grupo global com operações em múltiplos países. A companhia é conhecida por seu compromisso com a sustentabilidade, inovação e uso de ingredientes naturais, especialmente da biodiversidade amazônica. Natura &Co opera através de marcas renomadas incluindo Natura, Avon, The Body Shop e Aesop, atendendo consumidores em mais de 100 países. A empresa mantém um modelo de negócio inovador que combina vendas diretas, e-commerce e varejo tradicional. Natura &Co está comprometida com práticas sustentáveis, responsabilidade social e governança corporativa, posicionando-se como líder global em beleza sustentável e inc…", "enterpriseValue": 20572994000, "analystTargetLow": 0, "analystTargetHigh": 0, "analystTargetMean": 0, "fullTimeEmployees": null, "sharesOutstanding": 1390615200, "enterpriseToEbitda": 9.367904, "analystTargetMedian": 0, "enterpriseToRevenue": 0.95856947, "operatingCashflowTTM": -1514000000, "analystRecommendationKey": null } }, "createdAt": "2026-04-09T04:27:47.965Z" }, "results": [ { "id": "cmnqz7ngz00wnp658v0a574rg", "runId": "cmnqz7ngt00wjp658xw8lvf2w", "modelId": "anthropic", "status": "SUCCESS", "rawOutput": "{\"model\":\"ai-equity-research-v1\",\"as_of\":\"2026-04-08T21:30:33.000Z\",\"ticker\":\"NATU3\",\"currency\":\"BRL\",\"current_price\":10.35,\"target_price_6m\":11.15,\"target_price_12m\":12.0,\"recommendation\":\"BUY\",\"confidence\":0.55,\"thesis_bullets\":[\"Portfolio simplification (Aesop/TBS exits) sharpens focus on Natura+Avon brands\",\"Healthy 66% gross margin supports operating leverage as restructuring costs fade\",\"EV/EBITDA of 9.4x reasonable if EBITDA growth accelerates post-integration\",\"High net debt (~BRL 6.3B) constrains equity value and limits financial flexibility\",\"Negative FCF and net income reflect ongoing Avon integration and restructuring drag\"],\"key_drivers\":[{\"driver\":\"Avon integration synergies and cost rationalization\",\"impact\":\"HIGH\",\"direction\":\"POS\"},{\"driver\":\"Debt reduction trajectory and cash generation inflection\",\"impact\":\"HIGH\",\"direction\":\"POS\"},{\"driver\":\"Latin American direct-sales channel resilience\",\"impact\":\"MED\",\"direction\":\"POS\"},{\"driver\":\"Negative FCF and operating cash outflows weigh on valuation\",\"impact\":\"HIGH\",\"direction\":\"NEG\"},{\"driver\":\"Revenue growth anemic at ~1.9% YoY\",\"impact\":\"MED\",\"direction\":\"NEG\"},{\"driver\":\"FX exposure across multiple LatAm currencies\",\"impact\":\"MED\",\"direction\":\"NEG\"},{\"driver\":\"E-commerce and omnichannel digital transformation\",\"impact\":\"MED\",\"direction\":\"POS\"},{\"driver\":\"Sustainability/ESG brand premium among consumers\",\"impact\":\"LOW\",\"direction\":\"POS\"}],\"risks\":[\"Avon integration may take longer or cost more than expected, prolonging losses\",\"High leverage (net debt ~BRL 6.3B) exposes equity to refinancing and interest rate risk\",\"Continued negative FCF could force dilutive equity raise or asset sales\",\"LatAm macro slowdown and currency depreciation hurt reported results\",\"Competitive pressure from global beauty players and local D2C brands\"],\"assumptions\":{\"revenue_cagr_3y\":0.05,\"ebit_margin_target\":0.09,\"wacc\":0.14,\"terminal_multiple\":9.0},\"scenarios\":{\"bear\":{\"target_price\":7.5,\"prob\":0.25,\"notes\":\"EBITDA stagnates, integration falters, and leverage remains elevated.\"},\"base\":{\"target_price\":12.0,\"prob\":0.50,\"notes\":\"Avon synergies drive EBITDA to ~BRL 2.5B; moderate deleveraging supports re-rating.\"},\"bull\":{\"target_price\":17.0,\"prob\":0.25,\"notes\":\"Full integration success lifts EBITDA to ~BRL 3B; strong cash conversion enables debt paydown.\"}},\"method_notes\":\"EV/EBITDA-based valuation anchored on TTM EBITDA of BRL 2.2B with assumed improvement from Avon synergies. Base 12M EBITDA est. BRL 2.5B at 9x = EV BRL 22.5B less ~BRL 6B net debt / 1.39B shares ≈ BRL 12. Confidence is moderate due to negative FCF, high debt, and execution uncertainty on Avon turnaround. Not investment advice.\"}", "parsedJson": { "as_of": "2026-04-08T21:30:33.000Z", "model": "ai-equity-research-v1", "risks": [ "Avon integration may take longer or cost more than expected, prolonging losses", "High leverage (net debt ~BRL 6.3B) exposes equity to refinancing and interest rate risk", "Continued negative FCF could force dilutive equity raise or asset sales", "LatAm macro slowdown and currency depreciation hurt reported results", "Competitive pressure from global beauty players and local D2C brands" ], "ticker": "NATU3", "currency": "BRL", "scenarios": { "base": { "prob": 0.5, "notes": "Avon synergies drive EBITDA to ~BRL 2.5B; moderate deleveraging supports re-rating.", "target_price": 12 }, "bear": { "prob": 0.25, "notes": "EBITDA stagnates, integration falters, and leverage remains elevated.", "target_price": 7.5 }, "bull": { "prob": 0.25, "notes": "Full integration success lifts EBITDA to ~BRL 3B; strong cash conversion enables debt paydown.", "target_price": 17 } }, "confidence": 0.55, "assumptions": { "wacc": 0.14, "revenue_cagr_3y": 0.05, "terminal_multiple": 9, "ebit_margin_target": 0.09 }, "key_drivers": [ { "driver": "Avon integration synergies and cost rationalization", "impact": "HIGH", "direction": "POS" }, { "driver": "Debt reduction trajectory and cash generation inflection", "impact": "HIGH", "direction": "POS" }, { "driver": "Latin American direct-sales channel resilience", "impact": "MED", "direction": "POS" }, { "driver": "Negative FCF and operating cash outflows weigh on valuation", "impact": "HIGH", "direction": "NEG" }, { "driver": "Revenue growth anemic at ~1.9% YoY", "impact": "MED", "direction": "NEG" }, { "driver": "FX exposure across multiple LatAm currencies", "impact": "MED", "direction": "NEG" }, { "driver": "E-commerce and omnichannel digital transformation", "impact": "MED", "direction": "POS" }, { "driver": "Sustainability/ESG brand premium among consumers", "impact": "LOW", "direction": "POS" } ], "method_notes": "EV/EBITDA-based valuation anchored on TTM EBITDA of BRL 2.2B with assumed improvement from Avon synergies. Base 12M EBITDA est. BRL 2.5B at 9x = EV BRL 22.5B less ~BRL 6B net debt / 1.39B shares ≈ BRL 12. Confidence is moderate due to negative FCF, high debt, and execution uncertainty on Avon turnaround. Not investment advice.", "current_price": 10.35, "recommendation": "BUY", "thesis_bullets": [ "Portfolio simplification (Aesop/TBS exits) sharpens focus on Natura+Avon brands", "Healthy 66% gross margin supports operating leverage as restructuring costs fade", "EV/EBITDA of 9.4x reasonable if EBITDA growth accelerates post-integration", "High net debt (~BRL 6.3B) constrains equity value and limits financial flexibility", "Negative FCF and net income reflect ongoing Avon integration and restructuring drag" ], "target_price_6m": 11.15, "target_price_12m": 12 }, "errorsJson": { "attempts": [], "providerMeta": { "provider": "anthropic", "webSearch": { "enabled": false, "maxToolCalls": 2, "disabledReason": null }, "pauseTurns": 0, "stopReason": "end_turn" }, "sanityIssues": [] }, "latencyMs": 52006, "createdAt": "2026-04-09T04:27:47.979Z", "usage": { "inputTokens": 3732, "outputTokens": 1868, "costUsd": 0.06536 } }, { "id": "cmnqz7ngz00wqp658rws5iyb8", "runId": "cmnqz7ngt00wjp658xw8lvf2w", "modelId": "deepseek.reasoner", "status": "SUCCESS", "rawOutput": "{\n \"model\": \"Discounted Cash Flow Model\",\n \"as_of\": \"2026-04-08T21:30:33.000Z\",\n \"ticker\": \"NATU3\",\n \"currency\": \"BRL\",\n \"current_price\": 10.35,\n \"target_price_6m\": 10.2,\n \"target_price_12m\": 10.6,\n \"recommendation\": \"HOLD\",\n \"confidence\": 0.6,\n \"thesis_bullets\": [\"Strong brand portfolio with global reach\", \"Focus on sustainability and natural products\", \"Currently facing negative earnings and cash flow\", \"Moderate revenue growth but declining profitability\", \"High debt levels requiring careful management\"],\n \"key_drivers\": [\n {\"driver\": \"Revenue growth in new markets\", \"impact\": \"HIGH\", \"direction\": \"POS\"},\n {\"driver\": \"Margin improvement initiatives\", \"impact\": \"MED\", \"direction\": \"POS\"},\n {\"driver\": \"Debt reduction programs\", \"impact\": \"MED\", \"direction\": \"POS\"},\n {\"driver\": \"Economic sensitivity\", \"impact\": \"HIGH\", \"direction\": \"NEG\"},\n {\"driver\": \"Intense competition\", \"impact\": \"MED\", \"direction\": \"NEG\"},\n {\"driver\": \"Digital sales channel success\", \"impact\": \"MED\", \"direction\": \"POS\"}\n ],\n \"risks\": [\"Continued financial losses\", \"High leverage and interest costs\", \"Market competition pressure\", \"Execution risk in strategic plans\", \"Currency exchange rate volatility\"],\n \"assumptions\": {\n \"revenue_cagr_3y\": 0.03,\n \"ebit_margin_target\": 0.08,\n \"wacc\": 0.1,\n \"terminal_multiple\": 10\n },\n \"scenarios\": {\n \"bear\": {\"target_price\": 9.5, \"prob\": 0.3, \"notes\": \"Persistent losses lead to further price decline\"},\n \"base\": {\"target_price\": 10.6, \"prob\": 0.5, \"notes\": \"Steady improvement in margins and slight revenue growth\"},\n \"bull\": {\"target_price\": 12.0, \"prob\": 0.2, \"notes\": \"Significant operational turnaround and debt reduction\"}\n },\n \"method_notes\": \"Valuation based on DCF with growth and margin assumptions. HOLD due to mixed evidence and limited upside. Not investment advice.\"\n}", "parsedJson": { "as_of": "2026-04-08T21:30:33.000Z", "model": "Discounted Cash Flow Model", "risks": [ "Continued financial losses", "High leverage and interest costs", "Market competition pressure", "Execution risk in strategic plans", "Currency exchange rate volatility" ], "ticker": "NATU3", "currency": "BRL", "scenarios": { "base": { "prob": 0.5, "notes": "Steady improvement in margins and slight revenue growth", "target_price": 10.6 }, "bear": { "prob": 0.3, "notes": "Persistent losses lead to further price decline", "target_price": 9.5 }, "bull": { "prob": 0.2, "notes": "Significant operational turnaround and debt reduction", "target_price": 12 } }, "confidence": 0.6, "assumptions": { "wacc": 0.1, "revenue_cagr_3y": 0.03, "terminal_multiple": 10, "ebit_margin_target": 0.08 }, "key_drivers": [ { "driver": "Revenue growth in new markets", "impact": "HIGH", "direction": "POS" }, { "driver": "Margin improvement initiatives", "impact": "MED", "direction": "POS" }, { "driver": "Debt reduction programs", "impact": "MED", "direction": "POS" }, { "driver": "Economic sensitivity", "impact": "HIGH", "direction": "NEG" }, { "driver": "Intense competition", "impact": "MED", "direction": "NEG" }, { "driver": "Digital sales channel success", "impact": "MED", "direction": "POS" } ], "method_notes": "Valuation based on DCF with growth and margin assumptions. HOLD due to mixed evidence and limited upside. Not investment advice.", "current_price": 10.35, "recommendation": "HOLD", "thesis_bullets": [ "Strong brand portfolio with global reach", "Focus on sustainability and natural products", "Currently facing negative earnings and cash flow", "Moderate revenue growth but declining profitability", "High debt levels requiring careful management" ], "target_price_6m": 10.2, "target_price_12m": 10.6 }, "errorsJson": { "attempts": [], "providerMeta": { "endpoint": "https://api.deepseek.com/v1/chat/completions", "provider": "deepseek", "webSearch": { "enabled": false, "supported": false }, "responseFormat": "json_object" }, "sanityIssues": [] }, "latencyMs": 358, "createdAt": "2026-04-09T04:27:47.979Z", "usage": { "inputTokens": 2216, "outputTokens": 4128, "costUsd": 0.002354 } }, { "id": "cmnqz7ngz00wop6586ooklocc", "runId": "cmnqz7ngt00wjp658xw8lvf2w", "modelId": "gemini.3-pro", "status": "SUCCESS", "rawOutput": "{\n \"model\": \"AI Model Recommendation\",\n \"as_of\": \"2026-04-08T21:30:33.000Z\",\n \"ticker\": \"NATU3\",\n \"currency\": \"BRL\",\n \"current_price\": 10.35,\n \"target_price_6m\": 10.50,\n \"target_price_12m\": 10.80,\n \"recommendation\": \"HOLD\",\n \"confidence\": 0.65,\n \"thesis_bullets\": [\n \"Ongoing restructuring and Avon LatAm integration present significant execution risks.\",\n \"Divestments improved the capital structure but reduced the company's global footprint.\",\n \"Heavy net losses and negative FCF limit near-term capital return potential.\",\n \"Valuation at 9.4x EV/EBITDA appears fair given current margin pressures.\",\n \"Upside relies heavily on successful Avon turnaround and margin expansion in Brazil.\"\n ],\n \"key_drivers\": [\n {\n \"driver\": \"Avon LatAm Integration Synergies\",\n \"impact\": \"HIGH\",\n \"direction\": \"POS\"\n },\n {\n \"driver\": \"Restructuring and One-off Costs\",\n \"impact\": \"HIGH\",\n \"direction\": \"NEG\"\n },\n {\n \"driver\": \"Brazil Consumer Demand\",\n \"impact\": \"MED\",\n \"direction\": \"POS\"\n },\n {\n \"driver\": \"FX Volatility (BRL/USD)\",\n \"impact\": \"MED\",\n \"direction\": \"NEG\"\n },\n {\n \"driver\": \"Debt Servicing Costs\",\n \"impact\": \"MED\",\n \"direction\": \"NEG\"\n },\n {\n \"driver\": \"Direct Sales Channel Productivity\",\n \"impact\": \"MED\",\n \"direction\": \"POS\"\n }\n ],\n \"risks\": [\n \"Failure to realize projected Avon integration synergies in Latin America.\",\n \"Persistent negative free cash flow straining liquidity and balance sheet.\",\n \"Macroeconomic headwinds and inflation in key Latin American markets.\",\n \"Intense competition from local and global beauty brands.\"\n ],\n \"assumptions\": {\n \"revenue_cagr_3y\": 0.03,\n \"ebit_margin_target\": 0.08,\n \"wacc\": 0.125,\n \"terminal_multiple\": 8.0\n },\n \"scenarios\": {\n \"bear\": {\n \"target_price\": 7.50,\n \"prob\": 0.3,\n \"notes\": \"Integration stalls, margins remain depressed, and cash burn continues.\"\n },\n \"base\": {\n \"target_price\": 10.80,\n \"prob\": 0.5,\n \"notes\": \"Gradual margin recovery and successful Avon Wave 2 rollout in LatAm.\"\n },\n \"bull\": {\n \"target_price\": 14.00,\n \"prob\": 0.2,\n \"notes\": \"Faster-than-expected synergy realization and strong top-line growth in Brazil.\"\n }\n },\n \"method_notes\": \"Valuation based on a 10-year DCF and 8x terminal EV/EBITDA multiple. The HOLD recommendation reflects balanced risk/reward amid Avon integration execution risks and negative FCF. Not investment advice.\"\n}", "parsedJson": { "as_of": "2026-04-08T21:30:33.000Z", "model": "AI Model Recommendation", "risks": [ "Failure to realize projected Avon integration synergies in Latin America.", "Persistent negative free cash flow straining liquidity and balance sheet.", "Macroeconomic headwinds and inflation in key Latin American markets.", "Intense competition from local and global beauty brands." ], "ticker": "NATU3", "currency": "BRL", "scenarios": { "base": { "prob": 0.5, "notes": "Gradual margin recovery and successful Avon Wave 2 rollout in LatAm.", "target_price": 10.8 }, "bear": { "prob": 0.3, "notes": "Integration stalls, margins remain depressed, and cash burn continues.", "target_price": 7.5 }, "bull": { "prob": 0.2, "notes": "Faster-than-expected synergy realization and strong top-line growth in Brazil.", "target_price": 14 } }, "confidence": 0.65, "assumptions": { "wacc": 0.125, "revenue_cagr_3y": 0.03, "terminal_multiple": 8, "ebit_margin_target": 0.08 }, "key_drivers": [ { "driver": "Avon LatAm Integration Synergies", "impact": "HIGH", "direction": "POS" }, { "driver": "Restructuring and One-off Costs", "impact": "HIGH", "direction": "NEG" }, { "driver": "Brazil Consumer Demand", "impact": "MED", "direction": "POS" }, { "driver": "FX Volatility (BRL/USD)", "impact": "MED", "direction": "NEG" }, { "driver": "Debt Servicing Costs", "impact": "MED", "direction": "NEG" }, { "driver": "Direct Sales Channel Productivity", "impact": "MED", "direction": "POS" } ], "method_notes": "Valuation based on a 10-year DCF and 8x terminal EV/EBITDA multiple. The HOLD recommendation reflects balanced risk/reward amid Avon integration execution risks and negative FCF. Not investment advice.", "current_price": 10.35, "recommendation": "HOLD", "thesis_bullets": [ "Ongoing restructuring and Avon LatAm integration present significant execution risks.", "Divestments improved the capital structure but reduced the company's global footprint.", "Heavy net losses and negative FCF limit near-term capital return potential.", "Valuation at 9.4x EV/EBITDA appears fair given current margin pressures.", "Upside relies heavily on successful Avon turnaround and margin expansion in Brazil." ], "target_price_6m": 10.5, "target_price_12m": 10.8 }, "errorsJson": { "attempts": [], "providerMeta": { "model": "gemini-3-pro-preview", "provider": "gemini", "webSearch": { "used": false, "allowed": false, "enabled": false, "requested": false, "disabledReason": null } }, "sanityIssues": [] }, "latencyMs": 21325, "createdAt": "2026-04-09T04:27:47.979Z", "usage": { "inputTokens": 2416, "outputTokens": 811, "costUsd": 0.014564 } }, { "id": "cmnqz7ngz00wmp6586bqnvnt4", "runId": "cmnqz7ngt00wjp658xw8lvf2w", "modelId": "openai.gpt-5.4", "status": "SUCCESS", "rawOutput": "{\"model\":\"gpt-5\",\"as_of\":\"2026-04-08T21:30:33.000Z\",\"ticker\":\"NATU3\",\"currency\":\"BRL\",\"current_price\":10.35,\"target_price_6m\":10.7,\"target_price_12m\":10.95,\"recommendation\":\"HOLD\",\"confidence\":0.59,\"thesis_bullets\":[\"Brazil core brand remains resilient despite weak consolidated profitability.\",\"Turnaround and portfolio simplification can lift margins, but timing is uncertain.\",\"High gross margin supports recovery, yet operating cash flow stays negative.\",\"Leverage is manageable today, though sustained cash burn limits upside.\",\"Valuation near book value looks fair versus execution and macro risks.\"],\"key_drivers\":[{\"driver\":\"Brazil sales resilience\",\"impact\":\"HIGH\",\"direction\":\"POS\"},{\"driver\":\"Avon turnaround execution\",\"impact\":\"HIGH\",\"direction\":\"POS\"},{\"driver\":\"Cash burn reduction\",\"impact\":\"HIGH\",\"direction\":\"POS\"},{\"driver\":\"Net debt servicing\",\"impact\":\"HIGH\",\"direction\":\"NEG\"},{\"driver\":\"FX volatility\",\"impact\":\"MED\",\"direction\":\"NEG\"},{\"driver\":\"Channel mix to digital\",\"impact\":\"MED\",\"direction\":\"POS\"},{\"driver\":\"Promotional intensity\",\"impact\":\"MED\",\"direction\":\"NEG\"},{\"driver\":\"Portfolio simplification\",\"impact\":\"MED\",\"direction\":\"POS\"}],\"risks\":[\"Turnaround delays keep FCF negative\",\"Brazil and LatAm demand softens\",\"FX and inflation pressure margins\",\"Higher rates worsen leverage stress\"],\"assumptions\":{\"revenue_cagr_3y\":4.5,\"ebit_margin_target\":9,\"wacc\":13,\"terminal_multiple\":8.5},\"scenarios\":{\"bear\":{\"target_price\":8.2,\"prob\":0.3,\"notes\":\"Recovery stalls, margins stay weak and cash burn persists.\"},\"base\":{\"target_price\":10.95,\"prob\":0.45,\"notes\":\"Core brand stays resilient and margins recover gradually.\"},\"bull\":{\"target_price\":13.4,\"prob\":0.25,\"notes\":\"Simplification and execution lift margins and cash conversion faster.\"}},\"method_notes\":\"Uses snapshot data only; valuation is a normalized 12M EV/EBITDA cross-check with P/B given losses and negative FCF. Mixed evidence keeps expected return modest and supports HOLD. No sell-side targets used; not investment advice\"}", "parsedJson": { "as_of": "2026-04-08T21:30:33.000Z", "model": "gpt-5", "risks": [ "Turnaround delays keep FCF negative", "Brazil and LatAm demand softens", "FX and inflation pressure margins", "Higher rates worsen leverage stress" ], "ticker": "NATU3", "currency": "BRL", "scenarios": { "base": { "prob": 0.45, "notes": "Core brand stays resilient and margins recover gradually.", "target_price": 10.95 }, "bear": { "prob": 0.3, "notes": "Recovery stalls, margins stay weak and cash burn persists.", "target_price": 8.2 }, "bull": { "prob": 0.25, "notes": "Simplification and execution lift margins and cash conversion faster.", "target_price": 13.4 } }, "confidence": 0.59, "assumptions": { "wacc": 13, "revenue_cagr_3y": 4.5, "terminal_multiple": 8.5, "ebit_margin_target": 9 }, "key_drivers": [ { "driver": "Brazil sales resilience", "impact": "HIGH", "direction": "POS" }, { "driver": "Avon turnaround execution", "impact": "HIGH", "direction": "POS" }, { "driver": "Cash burn reduction", "impact": "HIGH", "direction": "POS" }, { "driver": "Net debt servicing", "impact": "HIGH", "direction": "NEG" }, { "driver": "FX volatility", "impact": "MED", "direction": "NEG" }, { "driver": "Channel mix to digital", "impact": "MED", "direction": "POS" }, { "driver": "Promotional intensity", "impact": "MED", "direction": "NEG" }, { "driver": "Portfolio simplification", "impact": "MED", "direction": "POS" } ], "method_notes": "Uses snapshot data only; valuation is a normalized 12M EV/EBITDA cross-check with P/B given losses and negative FCF. Mixed evidence keeps expected return modest and supports HOLD. No sell-side targets used; not investment advice", "current_price": 10.35, "recommendation": "HOLD", "thesis_bullets": [ "Brazil core brand remains resilient despite weak consolidated profitability.", "Turnaround and portfolio simplification can lift margins, but timing is uncertain.", "High gross margin supports recovery, yet operating cash flow stays negative.", "Leverage is manageable today, though sustained cash burn limits upside.", "Valuation near book value looks fair versus execution and macro risks." ], "target_price_6m": 10.7, "target_price_12m": 10.95 }, "errorsJson": { "attempts": [], "providerMeta": { "provider": "openai", "webSearch": { "used": false, "enabled": false, "sources": [], "maxToolCalls": 2 }, "responseId": "resp_056f2b84a310e2db0069d72cb4b1d08197871eddaf46cf1441", "reasoningEffort": "medium", "structuredOutputs": { "used": true, "requested": true, "disabledReason": null } }, "sanityIssues": [] }, "latencyMs": 34214, "createdAt": "2026-04-09T04:27:47.979Z", "usage": { "inputTokens": 2441, "outputTokens": 1810, "costUsd": 0.029612 } }, { "id": "cmnqz7ngz00wpp658pmwiqwzd", "runId": "cmnqz7ngt00wjp658xw8lvf2w", "modelId": "xai.grok-4.20-reasoning", "status": "SUCCESS", "rawOutput": "{\n \"model\": \"AI DCF Valuation Model\",\n \"as_of\": \"2026-04-08T21:30:33.000Z\",\n \"ticker\": \"NATU3\",\n \"currency\": \"BRL\",\n \"current_price\": 10.35,\n \"target_price_6m\": 11.2,\n \"target_price_12m\": 12.0,\n \"recommendation\": \"BUY\",\n \"confidence\": 0.58,\n \"thesis_bullets\": [\n \"Strong global brands with natural ingredients focus\",\n \"High debt and negative FCF limit flexibility\",\n \"Margin expansion potential via cost synergies\",\n \"Sustainability edge supports premium positioning\",\n \"Near book value offers valuation support\"\n ],\n \"key_drivers\": [\n {\n \"driver\": \"Iconic brand portfolio\",\n \"impact\": \"HIGH\",\n \"direction\": \"POS\"\n },\n {\n \"driver\": \"High leverage and interest costs\",\n \"impact\": \"HIGH\",\n \"direction\": \"NEG\"\n },\n {\n \"driver\": \"EBIT margin recovery\",\n \"impact\": \"HIGH\",\n \"direction\": \"POS\"\n },\n {\n \"driver\": \"Sustainability differentiation\",\n \"impact\": \"MED\",\n \"direction\": \"POS\"\n },\n {\n \"driver\": \"Negative free cash flow\",\n \"impact\": \"HIGH\",\n \"direction\": \"NEG\"\n },\n {\n \"driver\": \"Emerging markets growth\",\n \"impact\": \"MED\",\n \"direction\": \"POS\"\n },\n {\n \"driver\": \"Beauty sector competition\",\n \"impact\": \"MED\",\n \"direction\": \"NEG\"\n },\n {\n \"driver\": \"Brazil macro conditions\",\n \"impact\": \"MED\",\n \"direction\": \"NEG\"\n }\n ],\n \"risks\": [\n \"Persistent losses and negative EPS\",\n \"Debt burden risking financial strain\",\n \"Brand integration execution failures\",\n \"Currency volatility in key markets\"\n ],\n \"assumptions\": {\n \"revenue_cagr_3y\": 0.075,\n \"ebit_margin_target\": 0.105,\n \"wacc\": 0.115,\n \"terminal_multiple\": 11.5\n },\n \"scenarios\": {\n \"bear\": {\n \"target_price\": 8.0,\n \"prob\": 0.35,\n \"notes\": \"Ongoing losses trigger restructuring and dilution.\"\n },\n \"base\": {\n \"target_price\": 12.0,\n \"prob\": 0.45,\n \"notes\": \"Moderate margin gains and cash flow recovery.\"\n },\n \"bull\": {\n \"target_price\": 15.5,\n \"prob\": 0.2,\n \"notes\": \"Accelerated growth and debt reduction exceed forecasts.\"\n }\n },\n \"method_notes\": \"DCF using revenue CAGR, target EBIT margin, WACC and terminal multiple. BUY reflects 16% upside on recovery vs risks. not investment advice.\"\n}", "parsedJson": { "as_of": "2026-04-08T21:30:33.000Z", "model": "AI DCF Valuation Model", "risks": [ "Persistent losses and negative EPS", "Debt burden risking financial strain", "Brand integration execution failures", "Currency volatility in key markets" ], "ticker": "NATU3", "currency": "BRL", "scenarios": { "base": { "prob": 0.45, "notes": "Moderate margin gains and cash flow recovery.", "target_price": 12 }, "bear": { "prob": 0.35, "notes": "Ongoing losses trigger restructuring and dilution.", "target_price": 8 }, "bull": { "prob": 0.2, "notes": "Accelerated growth and debt reduction exceed forecasts.", "target_price": 15.5 } }, "confidence": 0.58, "assumptions": { "wacc": 0.115, "revenue_cagr_3y": 0.075, "terminal_multiple": 11.5, "ebit_margin_target": 0.105 }, "key_drivers": [ { "driver": "Iconic brand portfolio", "impact": "HIGH", "direction": "POS" }, { "driver": "High leverage and interest costs", "impact": "HIGH", "direction": "NEG" }, { "driver": "EBIT margin recovery", "impact": "HIGH", "direction": "POS" }, { "driver": "Sustainability differentiation", "impact": "MED", "direction": "POS" }, { "driver": "Negative free cash flow", "impact": "HIGH", "direction": "NEG" }, { "driver": "Emerging markets growth", "impact": "MED", "direction": "POS" }, { "driver": "Beauty sector competition", "impact": "MED", "direction": "NEG" }, { "driver": "Brazil macro conditions", "impact": "MED", "direction": "NEG" } ], "method_notes": "DCF using revenue CAGR, target EBIT margin, WACC and terminal multiple. BUY reflects 16% upside on recovery vs risks. not investment advice.", "current_price": 10.35, "recommendation": "BUY", "thesis_bullets": [ "Strong global brands with natural ingredients focus", "High debt and negative FCF limit flexibility", "Margin expansion potential via cost synergies", "Sustainability edge supports premium positioning", "Near book value offers valuation support" ], "target_price_6m": 11.2, "target_price_12m": 12 }, "errorsJson": { "attempts": [], "providerMeta": { "provider": "xai", "webSearch": { "used": false, "enabled": false, "sources": [], "maxToolCalls": 2 }, "responseId": "7c4a1e68-912b-9fa9-91f8-9931f8e29b36", "usedFallbackChatCompletions": false }, "sanityIssues": [] }, "latencyMs": 27543, "createdAt": "2026-04-09T04:27:47.979Z", "usage": { "inputTokens": 2782, "outputTokens": 4312, "costUsd": 0.073026 } } ] } }